OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adverse outcome and severity of COVID ‐19 in patients with autoimmune bullous diseases: A historical cohort study
Fateme Shirzad Moghadam, Nika Kianfar, Shayan Dasdar, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 9
Open Access | Times Cited: 10
Fateme Shirzad Moghadam, Nika Kianfar, Shayan Dasdar, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 9
Open Access | Times Cited: 10
Showing 10 citing articles:
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine
Anna Pira, Jo Linda Sinagra, Francesco Moro, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Anna Pira, Jo Linda Sinagra, Francesco Moro, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Rituximab treatment for refractory and moderate-to-severe pemphigus patients in the pandemic era: A single-center retrospective study
Ceylan Avcı, Gülfem Akın, Sevgi Akarsu, et al.
Dermatologica Sinica (2024) Vol. 42, Iss. 1, pp. 31-38
Open Access | Times Cited: 2
Ceylan Avcı, Gülfem Akın, Sevgi Akarsu, et al.
Dermatologica Sinica (2024) Vol. 42, Iss. 1, pp. 31-38
Open Access | Times Cited: 2
COVID-19 and autoimmune bullous diseases: Lessons learned
Michael Kasperkiewicz, David T. Woodley
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103286-103286
Open Access | Times Cited: 6
Michael Kasperkiewicz, David T. Woodley
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103286-103286
Open Access | Times Cited: 6
A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy
Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 7, pp. 934-944
Open Access | Times Cited: 5
Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 7, pp. 934-944
Open Access | Times Cited: 5
The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness
Nicole Maynard, April W. Armstrong
Current Dermatology Reports (2023) Vol. 12, Iss. 2, pp. 45-55
Open Access | Times Cited: 2
Nicole Maynard, April W. Armstrong
Current Dermatology Reports (2023) Vol. 12, Iss. 2, pp. 45-55
Open Access | Times Cited: 2
Rituximab in immunobullous disorders during the COVID ‐19 pandemic: A systematic review of observational studies
Michael Kasperkiewicz, David T. Woodley
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1
Closed Access | Times Cited: 4
Michael Kasperkiewicz, David T. Woodley
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1
Closed Access | Times Cited: 4
Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China
Jia‐Ling Zhang, S. Wang, Sheng‐Nan Cui, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 11, pp. 1433-1441
Closed Access | Times Cited: 1
Jia‐Ling Zhang, S. Wang, Sheng‐Nan Cui, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 11, pp. 1433-1441
Closed Access | Times Cited: 1
COVID outcome in pemphigus: Does rituximab make pemphigus patients susceptible to more severe COVID‐19?
Zeinab Aryanian, Kamran Balighi, Baseerat Sajad, et al.
Journal of Cosmetic Dermatology (2023) Vol. 22, Iss. 11, pp. 2880-2888
Open Access | Times Cited: 1
Zeinab Aryanian, Kamran Balighi, Baseerat Sajad, et al.
Journal of Cosmetic Dermatology (2023) Vol. 22, Iss. 11, pp. 2880-2888
Open Access | Times Cited: 1
A Rare Case of COVID-19-Induced Acute Exacerbation of Oral Dermatitis Herpetiformis in a Geriatric Patient
Amira Shafuria, Irna Sufiawati, Hermin Aminah Usman
International Medical Case Reports Journal (2023) Vol. Volume 16, pp. 129-134
Open Access
Amira Shafuria, Irna Sufiawati, Hermin Aminah Usman
International Medical Case Reports Journal (2023) Vol. Volume 16, pp. 129-134
Open Access
